EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.22.70 | drug development | the enzyme is is a promising target for therapies against Gram-positive bacteria, in general, and staphylococci, in particular | Staphylococcus aureus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.22.70 | recombinant expression of His6-tagged and of nontagged truncated enzyme mutant variant SrtADELTA59 in Escherichia coli strain BL21(DE3) | Staphylococcus aureus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.70 | 1-(3,4-dichlorophenyl)-3-(dimethylamino)propan-1-one | - |
Staphylococcus aureus | |
3.4.22.70 | 2-(1-oxoisoindolin-2-yl)acetic acid | - |
Staphylococcus aureus | |
3.4.22.70 | 2-(3-oxo-1,2-benzothiazol-2(3H)-yl)-N-(tricyclo[3.3.1.13,7]dec-1-yl)acetamide | - |
Staphylococcus aureus | |
3.4.22.70 | 3-(3-oxo-1,2-benzothiazol-2(3H)-yl)propanoic acid | - |
Staphylococcus aureus | |
3.4.22.70 | aminoadamantan | - |
Staphylococcus aureus | |
3.4.22.70 | methyl 1-aminoadamantan-3-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl 3-(3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamido)adamantane-1-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl 3-(3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamido)adamantane-1-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | additional information | small molecule library screening, synthesis and analysis of irreversible benzisothiazolinone-based inhibitors of the enzyme, structure-activity relationship, overview. No inhibition by aminoadamantan, methyl 1-aminoadamantan-3-carboxylate, and 2-(1-oxoisoindolin-2-yl)acetic acid. Structure determination of inhibitor 1-SrtA complex using purified recombinant nontagged truncated enzyme mutant variant SrtADELTA59, NMR structure determination and analysis | Staphylococcus aureus | |
3.4.22.70 | N'-(2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetyl)adamantane-1-carbohydrazide | - |
Staphylococcus aureus | |
3.4.22.70 | N'-(3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanoyl)adamantane-1-carbohydrazide | - |
Staphylococcus aureus | |
3.4.22.70 | N'-(3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanoyl)adamantane-1-carbohydrazide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3,5-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3,5-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3,5-dimethyladamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3-hydroxyadamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(3-ydroxyadamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-(adamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | N-adamantan-1-yl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | - |
Staphylococcus aureus | |
3.4.22.70 | phenyl vinyl sulfone | - |
Staphylococcus aureus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.22.70 | cell wall | - |
Staphylococcus aureus | 5618 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.70 | Ca2+ | required | Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.70 | Staphylococcus aureus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.22.70 | recombinant nontagged truncated enzyme mutant variant SrtADELTA59 from Escherichia coli strain BL21(DE3) by cation and anion exchange chromatography, dialysis, and gel filtration, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA59 from Escherichia coli strain BL21(DE3) by nickel affinity chromatography and gel filtration | Staphylococcus aureus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.22.70 | Dabcyl-QALPETGEE-Edans + H2O | - |
Staphylococcus aureus | Dabcyl-QALPET + GEE-Edans | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.22.70 | sortase A transpeptidase | - |
Staphylococcus aureus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.22.70 | 37 | - |
assay at | Staphylococcus aureus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.22.70 | 7.5 | - |
assay at | Staphylococcus aureus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.22.70 | 0.00339 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA74 | Staphylococcus aureus | N'-(3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanoyl)adamantane-1-carbohydrazide | |
3.4.22.70 | 0.0038 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA72 | Staphylococcus aureus | N'-(2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetyl)adamantane-1-carbohydrazide | |
3.4.22.70 | 0.00381 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA62 | Staphylococcus aureus | N-adamantan-1-yl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00387 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA61 | Staphylococcus aureus | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetamide | |
3.4.22.70 | 0.00396 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA69 | Staphylococcus aureus | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00401 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA67 | Staphylococcus aureus | N-(adamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.0041 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA68 | Staphylococcus aureus | N-(3,5-dimethyladamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00422 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA73 | Staphylococcus aureus | N'-(3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanoyl)adamantane-1-carbohydrazide | |
3.4.22.70 | 0.00462 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA63 | Staphylococcus aureus | N-(3,5-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00499 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA60 | Staphylococcus aureus | N-(3,5-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetamide | |
3.4.22.70 | 0.00506 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA71 | Staphylococcus aureus | methyl 3-(3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamido)adamantane-1-carboxylate | |
3.4.22.70 | 0.00508 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA66 | Staphylococcus aureus | methyl 3-(3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamido)adamantane-1-carboxylate | |
3.4.22.70 | 0.00611 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA59 | Staphylococcus aureus | 2-(3-oxo-1,2-benzothiazol-2(3H)-yl)-N-(tricyclo[3.3.1.13,7]dec-1-yl)acetamide | |
3.4.22.70 | 0.00626 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA70 | Staphylococcus aureus | N-(3-ydroxyadamantan-1-yl)-3-(4-fluoro-3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00644 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA65 | Staphylococcus aureus | N-(3-hydroxyadamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.00706 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA64 | Staphylococcus aureus | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)propanamide | |
3.4.22.70 | 0.0128 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA75 | Staphylococcus aureus | 3-(3-oxo-1,2-benzothiazol-2(3H)-yl)propanoic acid | |
3.4.22.70 | 0.0169 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA75 | Staphylococcus aureus | phenyl vinyl sulfone | |
3.4.22.70 | 0.736 | - |
pH 7.5, 37°C, recombinant His6-tagged truncated enzyme mutant variant SrtADELTA75 | Staphylococcus aureus | 1-(3,4-dichlorophenyl)-3-(dimethylamino)propan-1-one |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.22.70 | physiological function | as a transpeptidase that covalently attaches various virulence factors to the cell surface, this enzyme plays a crucial role in the ability of bacteria to invade the host's tissues and to escape the immune response | Staphylococcus aureus |